SlideShare ist ein Scribd-Unternehmen logo
1 von 48
Mycobacteriology
Update 2020
Margie Morgan, PhD, D(ABMM)
Mycobacteria
 Acid Fast Bacilli (AFB)
 Thick outer cell wall contains complex mycolic acids (mycolates) and
free lipids, contributes to the hardiness of the genus
 Once stained, AFB resist de-colorization with acid alcohol (HCl),
hence the term acid fast
 Difference of AFB stain vs. modified or partial acid fast (PAF) stain
 AFB stain uses HCl to decolorize Mycobacteria (+) Nocardia (-)
 PAF stain uses H2SO4 to decolorize Mycobacteria (+) Nocardia (+)
 AFB stain poorly with Gram stain / beaded Gram positive
 Aerobic, no spores, rarely branch
Kinyoun AFB stain Gram stain
Identification of the Mycobacteria
 For decades, identification algorithm started with determining the
ability of a mycobacteria species to form cartenoid pigment in the
light or dark; followed by biochemical reactions, growth rate, and
optimum temperature for growth. Obsolete
 With expanding taxonomy, biochemical reactions were unable to
separate and identify most of the newly recognized species, so
replaced with High Performance Liquid Chromatography (HPLC)
methods. Now also obsolete
 Current best methods for identification include:
 Genetic probes (DNA/RNA hybridization)
 MALDI-TOF Mass Spectrometry to analyze cellular proteins
 Sequencing 16 sRNA for precise genetic sequence information
Mycobacteria Taxonomy currently >170 species
with 2 Taxonomic groups
 Group 1 - TB complex organisms
 Mycobacterium tuberculosis
 M. bovis
 Bacillus Calmette-Guerin (BCG) strain
 Attenuated strain of M. bovis used for vaccination
 M. africanum
 Rare species of mycobacteria
 Mycobacterium microti
 Mycobacterium canetti
 Mycobacterium caprae
 Mycobacterium pinnipedii
 Mycobacterium suricattae
 Mycobacterium mungi
 Group 2 - Mycobacteria other than TB complex (“MOTT”) also
known as Non-Tuberculous Mycobacteria
Non tuberculous mycobacteria that cause disease
(1) Slowly growing non tuberculosis mycobacteria
 M. avium-intracullare complex
 M. genavense
 M. haemophilum
 M. kansasii (3) Mycobacterium leprae
 M. malmoense
 M. marinum
 M. simiae
 M. szulgai
 M. ulcerans
 M. xenopi
 M. smegmatis
(2) Rapid growing mycobacteria (growth in <= 7 days)
 M. fortuitum group
 M. abscessus
 M. chelonae
 M. mucogenicum
Mycobacteria that rarely if ever cause disease!
If so, only in the immunocompromised!
Slowly growing nontuberculous
mycobacteria
 Mycobacterium gordonae
 M. gastri
 M. celatum
 M. scrofulaceum
 M. terrae complex
Algorithm for identification of MOTT
- historically speaking
 Based on the “Runyon System”
 System used to classify non-tuberculous mycobacteria
 Based on carotenoid pigment production when exposed to incandescent
light bulb & growth rate
 Four Runyon groups
 Photochromogen = Pigment produced only when exposed to light
 Scotochromogen = Pigment produced in both light and dark
 Non-photochromogen = No pigment produced in either light or dark
 Rapid Grower = Growth rate (<= 7 days)
The Light Test – Determine if mycobacteria can produce a yellow
carotenoid pigment after being exposed to 8 hours of light/ after
light exposure, incubate for 24 hours and observe for pigment.
Group I Photochromogen
Turns yellow only after light exposure Group III
Non-photochromogen
No pigment produced in dark
or after light exposure
Group II Scotochromogen
Yellow pigment present in dark or
with light exposure
Runyon Classification System Classification
 Group I - Photochromogen – turns yellow when exposed
to light, no color in the dark. Growth in 2 -3 weeks
 M. kansasii
 M. simiae
 M. szulgai photochromagen when incubated at 25˚C*
 M. marinum
 Group II - Scotochromogen – yellow pigment in dark or
exposure to light. Growth 2 – 3 weeks
 M. gordonae
 M. scrofulaceum
 M. xenopi (most strains)
 M. szulgai scotochromogen when incubated at 37°C*
Runyon Classification continued
 Group III – Non-photochromogen – No pigment produced in
the light or dark, growth in 2-3 weeks
 M. avium-intracellulare complex
 M. haemophilum
 M. xenopi (some strains)
 Group IV – Rapid growers, grow in <=7 days
 M. fortuitum group
 M. abscessus
 M. chelonae
 M. mucogenicum
 M. smegmatis
AFB Laboratory
Safety
 Level 3 biosafety precautions required in AFB laboratories that process, identify and
perform susceptibility testing on mycobacteria species
 Level 2 Hepa filter biosafety cabinet with return air vented to the outside
 Biosafety certified at least yearly per regulation to insure proper operations
 Room under negative air flow, anteroom for safety gear donning, and contiguous autoclave
 Must wear a 95 respirator mask (yearly mask fit required) or PAPR (powered air purifying
respiratory mask) when working with organisms even when inside the biosafety cabinet
 Gloves and disposable surgical gowns for culture work
 Plastic cups with tight lids used during high speed centrifugation
Biosafety Cabinet
PAPR
Vented to outside
Specimen collection
 Sputum – 3 early morning collections, or
1 early morning, plus 2 collected at least 8 hours apart
 Bronchial lavage fluid
 Tissues or Lesions
 CSF or sterile body fluids
 Urine – 3 to 5 early morning collections
 Stool – Primarily for M. avium-intracellulare complex
 Gastric – usually only children unable to produce sputum,
must neutralize gastric to pH 7.0 after
collection in order for AFB to survive in stomach acid
 Blood / Bone marrow in disseminated disease
 Automated systems – AFB blood culture bottles
manufactured specifically for AFB detection
AFB Specimen Processing
Start to Finish!
 5 ml of specimen pipetted into conical Falcon tube
 Decontaminate and liquify sputum specimen for 15 minutes with:
 5 ml of 4% NaOH (increases the pH to 9) to kill contaminating bacteria
 N-acetyl-L-Cysteine – liquifies mucus plugs
 After 15 min - fill tube with phosphate buffer to neutralize to pH (7.0)
 Centrifuge for 30 minutes – using safety cups with tight lids
 3000 X g to pellet the AFB (speed is important – AFB are buoyant)
 Pour off the supernatant
 Prepare concentrated slide from pellet for AFB staining
 Dilute the pellet with small amount of sterile saline for culture
 Incubate culture media @ 37˚C, 5-10% CO2 for 6–8 weeks
Why Decontaminate Specimens?
Slow growing mycobacteria will be overgrown by “contaminating”
bacteria in the sputum specimen unless they are killed in the
decontamination step:
 Competing bacteria/yeast grow approximately 24 x faster than
AFB – these organisms are killed by the increased pH created
by the addition of 4% NaOH
 Must also release the AFB from mucus plugs in the sputum
specimen - this is accomplished with the addition of the
N-acetyl-L-Cysteine
Specimen Decontamination/Digestion of potentially
contaminated specimen types (respiratory)
 Routine processing:
 4% NaOH with N-acetyl-L-cysteine
 Processing: special circumstances/ cystic fibrosis
 Process sputum with oxalic acid to eliminate mucoid
strains of Pseudomonas aeruginosa
 4% NaOH will not kill these mucoid strains
 Oxalic acid should not be used routinely for processing all
specimens, will decrease yield of AFB in culture
 Both 4% NaOH and Oxalic acid can kill AFB if left on
specimen > 15 minutes.
Specimen Centrifugation
 Centrifugation at 3000 X g (high speed) with safety cups
 Speed of centrifugation is important –
 AFB are lipid laden and they will float if not rapidly centrifuged
 Pellet to bottom of tube so they are not decanted with supernatant
 Speed of centrifugation can effect the sensitivity of the AFB stain
 Pour off supernatant into waste
 Pellet used for stains/culture
Manual Plating/Culture Media
 Middlebrook – Synthetic media
 Clear colored solid agar and liquid media
 Synthetic = Known chemical ingredients added for optimal growth
 Used for both culture and susceptibility testing
 Autoclave to sterilize the media
 Lowenstein-Jensen – Egg based
 Solid agar, green due to addition of malachite green
 Ingredients: Hens egg, glycerol, and potato flour
 Used for culture only
 Sterilize by inspissation – drying
 Cultures incubated at 37˚C , 5-10% C0₂ for 6-8 weeks
Automated Detection of AFB
BD BACTEC MGIT 960 automated instrument for AFB
 Middlebrook 12B liquid media used for the culture of AFB
 BACTEC detection method
 As AFB grow in the 12B media, the AFB respire CO₂ and the amount of O₂ is
decreased over time. The lower level of O₂ causes fluorescence of the indicator and at
the bottom of the tube and indicates organism growth in the tube.
 Incubation at 37˚C for 6 weeks
Fluorescence
 NAP test /Identification of TB complex organisms
using MGIT 960 instrument
NAP = chemical (p-nitro-α-acetylamino-B-hydroxypropiophenone)
TB complex does not grow in the tube containing NAP
Non-tuberculous species grow in the tube containing the NAP chemical
MGIT 960
Acid Fast Stains for Mycobacteria
 Carbol Fuchsin based stains
 Carbol Fuchsin is red colored stain of the AFB
 Potassium permanganate is the background blue counterstain
 Two methods:
 Ziehl-Neelsen (ZN) – heat used to drive stain into lipid laden AFB
 Kinyoun – High % of phenol in stain drives stain into AFB
 Read numerous microscopic fields for 5 minutes, using light microscopy
using 100x oil objective
Fluorochrome based stain
 Auramine Rhodamine stain
 Fluorescent stain
 Rods stain fluorescent yellow with black background
 Read on 25X or 40X for 2 min, viewing numerous fields using
a fluorescence microscope
 Based on nonspecific fluoro-chrome that binds to the mycolic
acids in the mycobacteria
 Considered more sensitive than ZN or Kinyoun stains for
concentrated patient specimen slide examination
Acid Fast Mycobacteria morphology
Mycobacterium avium complex
Organisms are routinely shorter than TB
(Kinyoun stain) without cording. The
organisms tend to clump.
M. tuberculosis - Organisms are long
rods and can appear as if they are sticking
together [due ti cord factor]
In broth
cultures -
ropes of AFB
can form due to
cord factor
Direct Detection of TB from Respiratory Specimens
using Molecular Amplification
 FDA cleared DNA PCR that detects TB complex organisms in < 2 hrs for
both AFB smear positive and negative sputum specimens:
 Cepheid Xpert-TB RIF Assay (rtPCR) tested on the Genexpert instrument
 Detects TB complex organism gene sequence and rifampin resistance gene (rpoB)
 Sensitivity of assays
 99% for AFB concentrated smear (+) specimens
 75% for AFB concentrated smear (-) specimens
 Test of diagnosis, not cure
 Residual rRNA and DNA can be present for up to 6 months after initial
diagnosis and start of therapy
 Must confirm all tests with AFB culture and sensitivity (gold standard)
 Currently, no FDA cleared assay for non-tuberculous mycobacteria spp.
PPD (Purified Protein Derivative)
Mantoux test/TB skin test
 Detects latent or current TB exposure
 False positive reactions can occur in patients immunized with BCG
 @ 25% false negative reactions
 Usually due to low T cell numbers or T cell reactivity, such as occurs with high dose
steroids.
 Technical problems with PPD administration and test interpretation can also lead to
false negative or false positive reactions
 Measures delayed hypersensitivity (T cell response) to TB complex
antigens (not specific for TB)
 Measure (mm) area of induration at injection site
 >=15mm positive (check for history of BCG)
 >=10mm positive in immune suppressed or just exposed to TB and part of an
outbreak investigation
Cell Mitogen assays –
Interferon Gamma Release Assays (IGRA)s
 QuantiFERON-TB-Gold Plus (QFTP)
 CD4 and CD8 T cells in patient whole blood samples are stimulated
with TB specific antigens.
 If patient has active or latent exposure to TB, the stimulated T cells
will produce gamma interferon
 Automated EIA assay measures amount of gamma interferon
produced
 Quantitative endpoint indicates a positive or negative reaction
 Indeterminate reactions can occur, if T cells are absent or inactive
due to medications
 No false positive reactions from immunization with BCG
 Sensitivity >=80%, does NOT replace culture for disease diagnosis
 Sensitivity similar to PPD/ but has improved specificity
Mycobacterium tuberculosis
 Optimal Temp 37˚ C, Growth in 12 –25 days
 Buff colored, dry cauliflower-like colony
 Manual tests for identification – old school
 Niacin accumulation test positive
 Niacin produced from growth of TB on egg containing medium (LJ)
 Nitrate reduction test positive
 Current identification methods:
 Molecular DNA/RNA hybridization probe for MTB complex
 MALDI-TOF mass spectrometry for M. tuberculosis
 16 sRNA sequencing for M. tuberculosis
Mycobacterium tuberculosis
Cord factor – Due to high lipid content
in cell wall, rods stick together and
develop long ropes when grown in broth
media – unique to M. tuberculosis
Long AFB / stick together
Susceptibility testing of TB
 Two methods for testing
 (1) Agar dilution (indirect proportion method)
 Antibiotics embedded in solid agar and TB inoculated onto media quadrants
 (2) Liquid 7H12 medium containing anti-TB antibiotic solutions
 Tested on automated Bactec MGIT 960 system
 Primary TB drug panel / 5 drugs
 Isoniazid Ethambutol
 Pyrazinamide Streptomycin
 Rifampin
 If resistant to primary drugs, second line drugs tested
 Fluoroquinolones, Kanamycin, Amikacin, and Capreomycin
 If patient remains culture positive after four months on treatment/
retest the TB susceptibility / possible drug resistant strain
Tuberculosis
 Classic disease is slowly progressive pulmonary infection cough,
weight loss, and low grade fever, presentation can vary depending
on degree of immune suppression:
 Ghon’s complex: Lesion with calcified foci of infection and an associated lymph
node
 Miliary TB: Wide spread dissemination of infection via the bloodstream, occurs
most often in AIDS, elderly, children, immunosuppression and with some
medications (Remicade- infliximab)
 Secondary tuberculosis: mostly in adults as reactivation of previous infection
 Granulomatous inflammation much more florid and widespread than in primary disease.
 Upper lung lobes are most affected, and cavitation can occur.
 TB is spread by respiratory droplets
 All patients with high level of suspicion require respiratory isolation precautions
TB infection
Lung nodules
Pathology of Mycobacterium tuberculosis
Hallmark of Mycobacterium tuberculosis infected tissue is
necrotizing granulomatous inflammation,
• composed of epithelioid histiocytes surrounding a central
necrotic zone, and
• accompanied by a variable number of multinucleated giant cells
and lymphocytes.
• Non-necrotizing granulomas can also be present.
Nodule with
cavitation
Necrotizing
granuloma
TB in HIV/AIDS patients
 Worldwide -TB is the most common opportunistic infection affecting
HIV/AIDS patients
 TB more likely to be multi-drug resistant (at least INH and Rifampin)
 With progressive decline of cell mediated immunity (low CD4 count) –
greater risk of extra pulmonary (miliary) dissemination
 Granulomas with/without caseation can occur
Miliary TB
M. tuberculosis outside the lung
 Scrofula –Unilateral lymphadenitis (cervical lymph node)
most often seen in immunocompromised adult or children/
caseous necrosis often present
 Fine needle aspiration for diagnostic specimen
 M. tuberculosis most common in adults
 M. avium complex and other MOTT (2-10%) in children
 Pott’s disease - TB infection of the spine
 Secondary to an extra-spinal source of infection (1* pulmonary)
 Manifests as a combination of osteomyelitis and arthritis
that usually involves more than 1 vertebra.
Mycobacterium bovis
 Produces disease in warm blooded animals, cattle
 Spread to humans by inhalation of droplets or raw milk products
 Disease in humans similar to that caused by TB
 Differentiation of M. bovis from M. tuberculosis
M.bovis M. tb
Nitrate Negative Positive
Growth in T2H* No growth Growth
Pyrazinamidase enzyme Negative Positive
Pyrazinamide susceptibility Resistant Susceptible
*(Thiophene-2-carboxylic hydrazide)
 M. bovis BCG (Bacillus Calmette-Guerin)
 BCG is an attenuated strain of M. bovis
 Used for TB vaccination in countries with high prevalence of TB
 Instillation of BCG into bladder can be used to treat bladder cancer / some patients become
infected with the M. bovis BCG
Mycobacterium ulcerans
 Buruli ulcer in Africa and known as Bairnsdale ulcer in Australia
 Localized painless skin nodule evolves rapidly to ulceration and can
become disabling, due to production of mycolactones (cell cytotoxin)
 Endemic in tropical areas with limited medical care, mild skin trauma with
exposure to contaminated stagnant waters leads to progressive and
destructive ulcers, peak age group 5-15 yrs
 Optimum growth temp @ 30˚ C
 Does not grow well or at all at 37*C
 **Skin lesions suspect for AFB should be cultured at both 30˚ and 37˚C
 Difficult / slow growing requiring 3- 4 weeks/ molecular techniques preferred
Mycobacterium kansasii
 Culture 37* C, 10-20 days
 Photochromogen
 Niacin accumulation test negative
 Nitrate reduction positive
 Tween 80 positive / tests for presence of the lipase enzyme
 68*C catalase positive
 AFB are larger than TB - rectangular and very beaded with Shepherd’s
crook shape
 Clinical disease mimics pulmonary TB but less likely to disseminate
 Disease acquired from contaminated tap water
 Predisposition for diseased lung (COPD)
 More likely seen in immune suppressed, pneumoconiosis, alcohol abuse, and HIV
 Produces granulomatous inflammation in lung
Mycobacterium marinum
 Photochromogen
 Optimum temp for growth is 30˚ C
 Grows poorly or not at all at 37°C
 Grows in 5-14 days
 Normal habitat is contaminated fresh and salt water
 Infection associated with skin trauma occurring in water, such as
 Swimming pools (swimming pool granuloma)
 Cleaning fish tanks with bare hand and arm
 Ocean (surfing)
 Punctures from fish fins
Mycobacterium marinum
 Disease: Tender, red or blue/red subcutaneous nodules develop at
the site of trauma after 2-3 weeks
 Biopsy skin nodules for culture and histopathology
 Lesions classically spread up arm along lymphatics,
 Infection appears similar to diseases Sporotrichosis, Nocardiosis,
and infection with rapid growing Mycobacteria species
Mycobacterium szulgai
 Scotochromogen at 37˚C / Photochromogen at 25˚C
 Only AFB species that has a different light test result based on temperature
of incubation
 Grows at 37 ˚C in 12 - 25 days
 Rare cause of pulmonary
disease in adults associated with
alcohol abuse , smoking and COPD
or those with AIDS and immune suppressed
 Symptoms similar to TB
25˚ C - Photochromogen
37˚ C - Scotochromogen
Mycobacterium xenopi
 Scotochromogen
 Thermophilic AFB with growth at 42˚C
 Capable of growing in hot water systems and is the
usual source of infection
 Growth in 14 - 28 days
 Egg nest type colony produced on solid media
 Rare cause of pulmonary disease
 Clinical disease is like TB
 Occurs in patients with preexisting lung disease (chronic obstructive
pulmonary disease or bronchiectasis) and HIV/AIDS
M. avium complex
 M avium & M intracellulare most common species in this complex,
 The complex includes eight species of environmental and animal AFB
 Non-photochromogen
 All species biochemically and genetically very similar
 Growth at 37 ˚C / 7 – 21 days
 Smooth / creamy colony / buff colored
 Short rods, not beaded, irregular clumps of AFB
 Inert in biochemical reactions
 Identify using
 Molecular DNA/RNA hybridization probe (M. avium complex)
 MALDI-TOF mass spectrometry (species within complex)
 16s rRNA sequencing (species within complex)
M. avium complex clinical correlation
 Disease in the somewhat normal host
 Adults mostly have chronic pulmonary disease, fibro-cavitary or
nodular bronchiectatic disease presentation
 Elderly adults with prior lung damage (COPD) produces chronic
cough
 Children – chronic granulomatous inflammation with lymph node
involvement / scrofula
 M. chimaera (a species within the M. avium complex)
 Environmental / nosocomial pathogen
 Recently in the news as a contaminate in heater–cooler units used in cardiac
surgery/ aerosolized water from instrument positive with M. chimaera
 The airborne transmission of M. chimaera over an open surgical field caused post
surgical infections
M. avium complex (MAC)
 HIV/AIDS – common opportunistic infection in AIDS
 Nonspecific low grade fever, weakness, weight loss, picture of
fever of unknown origin rather than a pulmonary infection
 Diagnosis: Isolation of MAC from an AFB blood cuor
bone marrow culture
 Abdominal pain and/or diarrhea with malabsorption
 Positive AFB smears from stool specimens
 In tissue:
 Pathology: non-necrotizing more so than granulomatous
 High organism load in infected tissue
 AFB are small (short) rods and not beaded
 Does not have cord factor
M avium-complex in lymph node tissue
(AFB Kinyoun stain) – packed with AFB
Granulomatous inflammation
lung tissue (H&E stain)
Bowel -Lamina propria expanded from
predominately Lymphohistocytic infiltration
 Grows in <=7 days, more rapid than other mycobacteria species
 Low virulence organisms, with most species found as environmental
contaminates
 20 species – 3 species most common
 M. fortuitum skin and surgical wound infections, catheter sites
 M. chelonae skin infections in immune suppressed, catheter sites
 M. abscessus chronic lung infection and skin infection in immune suppressed
 Biochemical reactions:
 All species Arylsulfatase positive
 M. fortuitum: Nitrate reduction positive
Iron uptake positive
 M. chelonae and M. abscessus: Nitrate negative
Rapid Grower Mycobacteria species
 MALDI-TOF and 16 sRNA sequencing for identification
 Antibiotic therapy assisted by directed susceptibility tests
 Varying susceptibility patterns/ clarithromycin primary therapy
 Molecular genetic testing can assist with clarithromycin testing
Miscellaneous
 M. gordonae –
 Scotochromogen
 Rarely if ever causes infection
 Commonly found in tap water
 Find it’s way into AFB cultures as a laboratory contaminant
 Use sterile/distilled water in AFB culture collection and
processing to prevent culture contamination
Miscellaneous pathogenic species
 Mycobacterium haemophilum
 Fastidious AFB, requires addition of hemoglobin or hemin to
culture media for growth
 Will not grow on LJ media or in automated systems (Middlebrook 12B
media) without the addition of hemin supplements
 Grows best at 30*C
 Disease:
 Painful subcutaneous nodules and ulcers, primarily in AIDS patients or
immunosuppressed
 Lymphadenitis in children
Mycobacterium leprae
 Leprosy – Hansen’s Disease
 Affects the skin, peripheral nervous system and mucous membranes
 Clinical signs and symptoms aid in diagnosis: Peripheral neuropathy with nerve
thickening, numbness in earlobes or nose, loss of eye brows
 Infection by person-person spread via inhalation of infectious droplets
 Curable with early diagnosis and appropriate therapy (dapsone with rifampin or
clofazimine
 Two types of leprosy / most often found in India, Brazil and Indonesia
 Lepromatous – Severe disfiguring lesions, large numbers of AFB in lesions
 Tuberculoid - Less severe and fewer lesions, lower numbers of AFB in lesions
 Non-culturable on laboratory media
 PCR performed from tissue for definitive diagnosis
 Armadillo is a natural reservoir of M. leprae
Tuberculoid leprosy/
Paucibacillary
Lepromatous leprosy /Multibacillary
Skin biopsy - AFB seen in nerve fiber
AFB in “cigar packet” arrangement

Weitere ähnliche Inhalte

Was ist angesagt?

Was ist angesagt? (20)

Aspergillosis- Dr. Praveen kumar Doddamani
Aspergillosis-   Dr. Praveen kumar DoddamaniAspergillosis-   Dr. Praveen kumar Doddamani
Aspergillosis- Dr. Praveen kumar Doddamani
 
Fungal diagnosis
Fungal diagnosisFungal diagnosis
Fungal diagnosis
 
The neisseriae
The neisseriaeThe neisseriae
The neisseriae
 
Mycobacterium .pptx
Mycobacterium .pptxMycobacterium .pptx
Mycobacterium .pptx
 
Medical Microbiology Laboratory (Mycobacterium spp.)
Medical Microbiology Laboratory (Mycobacterium spp.)Medical Microbiology Laboratory (Mycobacterium spp.)
Medical Microbiology Laboratory (Mycobacterium spp.)
 
HISTOPLASMOSIS.pptx
HISTOPLASMOSIS.pptxHISTOPLASMOSIS.pptx
HISTOPLASMOSIS.pptx
 
Pseudomonas
PseudomonasPseudomonas
Pseudomonas
 
Mycology Update 2017
Mycology Update 2017Mycology Update 2017
Mycology Update 2017
 
Mycology -introduction and lab diagnosis with QC
Mycology -introduction and lab diagnosis with QCMycology -introduction and lab diagnosis with QC
Mycology -introduction and lab diagnosis with QC
 
MORAXELLA- Osan.pptx
MORAXELLA- Osan.pptxMORAXELLA- Osan.pptx
MORAXELLA- Osan.pptx
 
Strep pneumoniae
Strep pneumoniaeStrep pneumoniae
Strep pneumoniae
 
16. enterobacteriaceae
16. enterobacteriaceae16. enterobacteriaceae
16. enterobacteriaceae
 
Enterobacter, hafnia &amp; serratia (1)
Enterobacter, hafnia &amp; serratia (1)Enterobacter, hafnia &amp; serratia (1)
Enterobacter, hafnia &amp; serratia (1)
 
Mycology introduction hpv
Mycology introduction hpvMycology introduction hpv
Mycology introduction hpv
 
Pseudomonas.ppt
Pseudomonas.pptPseudomonas.ppt
Pseudomonas.ppt
 
Klebsiella spp
Klebsiella sppKlebsiella spp
Klebsiella spp
 
CLS Histoplasmosis.pptx
CLS Histoplasmosis.pptxCLS Histoplasmosis.pptx
CLS Histoplasmosis.pptx
 
Mycology Update 2023
Mycology Update 2023Mycology Update 2023
Mycology Update 2023
 
Mycology 2022
Mycology 2022Mycology 2022
Mycology 2022
 
Bacteriology Update 2021 (Part 2.)
Bacteriology Update 2021 (Part 2.)Bacteriology Update 2021 (Part 2.)
Bacteriology Update 2021 (Part 2.)
 

Ähnlich wie Mycobacteriology Update 2020: Identification Methods

Mycobacteriology 2021
Mycobacteriology 2021Mycobacteriology 2021
Mycobacteriology 2021Margie Morgan
 
Mycobacteriology Update 2018
Mycobacteriology Update 2018Mycobacteriology Update 2018
Mycobacteriology Update 2018Margie Morgan
 
Mycobacteriology 2016
Mycobacteriology 2016Mycobacteriology 2016
Mycobacteriology 2016Margie Morgan
 
Website mycobacteriology 2017 update
Website  mycobacteriology 2017 updateWebsite  mycobacteriology 2017 update
Website mycobacteriology 2017 updateMargie Morgan
 
Mycobacteriology Update 2023
Mycobacteriology Update 2023Mycobacteriology Update 2023
Mycobacteriology Update 2023Margie Morgan
 
Mycobacteriology Review 2019
Mycobacteriology Review 2019Mycobacteriology Review 2019
Mycobacteriology Review 2019Margie Morgan
 
Mycobacteriology update 2024 Margie Morgan.ppt
Mycobacteriology update 2024 Margie Morgan.pptMycobacteriology update 2024 Margie Morgan.ppt
Mycobacteriology update 2024 Margie Morgan.pptMargie Morgan
 
fungal diagnosis.pptx
fungal diagnosis.pptxfungal diagnosis.pptx
fungal diagnosis.pptxRashaAlNagar
 
Laboratory diagnosis of tuberculosis pract.
Laboratory diagnosis of tuberculosis pract.Laboratory diagnosis of tuberculosis pract.
Laboratory diagnosis of tuberculosis pract.deepak deshkar
 
Mycobacterium I.pptx
Mycobacterium I.pptxMycobacterium I.pptx
Mycobacterium I.pptxNithya243636
 
Corynebacterium (1)
Corynebacterium (1)Corynebacterium (1)
Corynebacterium (1)Noel4leon
 
Corynebacterium (1)
Corynebacterium (1)Corynebacterium (1)
Corynebacterium (1)Noel4leon
 
Bacteriology Update 2020
Bacteriology Update 2020Bacteriology Update 2020
Bacteriology Update 2020Margie Morgan
 
Detailed examination of tuberculosis in microbiology laboratory including zn ...
Detailed examination of tuberculosis in microbiology laboratory including zn ...Detailed examination of tuberculosis in microbiology laboratory including zn ...
Detailed examination of tuberculosis in microbiology laboratory including zn ...Umair Raza
 
SDA culture media
SDA culture media SDA culture media
SDA culture media Vamsi kumar
 
Afb stain by manoj
Afb stain by manojAfb stain by manoj
Afb stain by manojManoj Mahato
 

Ähnlich wie Mycobacteriology Update 2020: Identification Methods (20)

Mycobacteriology 2021
Mycobacteriology 2021Mycobacteriology 2021
Mycobacteriology 2021
 
Mycobacteriology Update 2018
Mycobacteriology Update 2018Mycobacteriology Update 2018
Mycobacteriology Update 2018
 
Mycobacteriology 2016
Mycobacteriology 2016Mycobacteriology 2016
Mycobacteriology 2016
 
Website mycobacteriology 2017 update
Website  mycobacteriology 2017 updateWebsite  mycobacteriology 2017 update
Website mycobacteriology 2017 update
 
Mycobacteriology
MycobacteriologyMycobacteriology
Mycobacteriology
 
Mycobacteriology Update 2023
Mycobacteriology Update 2023Mycobacteriology Update 2023
Mycobacteriology Update 2023
 
Mycobacteriology Review 2019
Mycobacteriology Review 2019Mycobacteriology Review 2019
Mycobacteriology Review 2019
 
Mycobacteriology update 2024 Margie Morgan.ppt
Mycobacteriology update 2024 Margie Morgan.pptMycobacteriology update 2024 Margie Morgan.ppt
Mycobacteriology update 2024 Margie Morgan.ppt
 
fungal diagnosis.pptx
fungal diagnosis.pptxfungal diagnosis.pptx
fungal diagnosis.pptx
 
Laboratory diagnosis of tuberculosis pract.
Laboratory diagnosis of tuberculosis pract.Laboratory diagnosis of tuberculosis pract.
Laboratory diagnosis of tuberculosis pract.
 
Mycobacterium I.pptx
Mycobacterium I.pptxMycobacterium I.pptx
Mycobacterium I.pptx
 
Corynebacterium (1)
Corynebacterium (1)Corynebacterium (1)
Corynebacterium (1)
 
Corynebacterium (1)
Corynebacterium (1)Corynebacterium (1)
Corynebacterium (1)
 
Bacteriology Update 2020
Bacteriology Update 2020Bacteriology Update 2020
Bacteriology Update 2020
 
2 specimen collection
2 specimen collection2 specimen collection
2 specimen collection
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Detailed examination of tuberculosis in microbiology laboratory including zn ...
Detailed examination of tuberculosis in microbiology laboratory including zn ...Detailed examination of tuberculosis in microbiology laboratory including zn ...
Detailed examination of tuberculosis in microbiology laboratory including zn ...
 
Ziehl and neelsen (acid fast) staining 2
Ziehl and neelsen (acid fast) staining 2Ziehl and neelsen (acid fast) staining 2
Ziehl and neelsen (acid fast) staining 2
 
SDA culture media
SDA culture media SDA culture media
SDA culture media
 
Afb stain by manoj
Afb stain by manojAfb stain by manoj
Afb stain by manoj
 

Mehr von Margie Morgan

Susceptibility Update 2024 | Microbes with Morgan
Susceptibility Update 2024 | Microbes with MorganSusceptibility Update 2024 | Microbes with Morgan
Susceptibility Update 2024 | Microbes with MorganMargie Morgan
 
WEB BACTERIOLOGY 2024 | Microbes With Morgan
WEB BACTERIOLOGY 2024 | Microbes With MorganWEB BACTERIOLOGY 2024 | Microbes With Morgan
WEB BACTERIOLOGY 2024 | Microbes With MorganMargie Morgan
 
Virology 2024 | Microbes with Morgan 2024
Virology 2024 | Microbes with Morgan 2024Virology 2024 | Microbes with Morgan 2024
Virology 2024 | Microbes with Morgan 2024Margie Morgan
 
Parasitology 2024 | Microbes with Morgan
Parasitology 2024 | Microbes with MorganParasitology 2024 | Microbes with Morgan
Parasitology 2024 | Microbes with MorganMargie Morgan
 
Mycology Update February 2024 Microbes with Morgan
Mycology Update February 2024 Microbes with MorganMycology Update February 2024 Microbes with Morgan
Mycology Update February 2024 Microbes with MorganMargie Morgan
 
Web Bacteriology 2023
Web Bacteriology 2023Web Bacteriology 2023
Web Bacteriology 2023Margie Morgan
 
VIROLOGY REVIEW 2023
VIROLOGY REVIEW 2023VIROLOGY REVIEW 2023
VIROLOGY REVIEW 2023Margie Morgan
 
Bacteriology Update 2021 (Part 1.)
Bacteriology Update 2021 (Part 1.)Bacteriology Update 2021 (Part 1.)
Bacteriology Update 2021 (Part 1.)Margie Morgan
 
Mycology Update 2021
Mycology Update 2021Mycology Update 2021
Mycology Update 2021Margie Morgan
 
Antibiotic Sensitivity Testing 2020 Update
Antibiotic Sensitivity Testing 2020 Update Antibiotic Sensitivity Testing 2020 Update
Antibiotic Sensitivity Testing 2020 Update Margie Morgan
 
Virology Review 2020
Virology Review 2020Virology Review 2020
Virology Review 2020Margie Morgan
 
Virology Review 2019
Virology Review 2019Virology Review 2019
Virology Review 2019Margie Morgan
 
Bacteriology Update 2019
Bacteriology Update 2019Bacteriology Update 2019
Bacteriology Update 2019Margie Morgan
 

Mehr von Margie Morgan (20)

Susceptibility Update 2024 | Microbes with Morgan
Susceptibility Update 2024 | Microbes with MorganSusceptibility Update 2024 | Microbes with Morgan
Susceptibility Update 2024 | Microbes with Morgan
 
WEB BACTERIOLOGY 2024 | Microbes With Morgan
WEB BACTERIOLOGY 2024 | Microbes With MorganWEB BACTERIOLOGY 2024 | Microbes With Morgan
WEB BACTERIOLOGY 2024 | Microbes With Morgan
 
Virology 2024 | Microbes with Morgan 2024
Virology 2024 | Microbes with Morgan 2024Virology 2024 | Microbes with Morgan 2024
Virology 2024 | Microbes with Morgan 2024
 
Parasitology 2024 | Microbes with Morgan
Parasitology 2024 | Microbes with MorganParasitology 2024 | Microbes with Morgan
Parasitology 2024 | Microbes with Morgan
 
Mycology Update February 2024 Microbes with Morgan
Mycology Update February 2024 Microbes with MorganMycology Update February 2024 Microbes with Morgan
Mycology Update February 2024 Microbes with Morgan
 
Web Bacteriology 2023
Web Bacteriology 2023Web Bacteriology 2023
Web Bacteriology 2023
 
Gram Stain 2023
Gram Stain 2023Gram Stain 2023
Gram Stain 2023
 
Susceptibility 2023
Susceptibility 2023Susceptibility 2023
Susceptibility 2023
 
VIROLOGY REVIEW 2023
VIROLOGY REVIEW 2023VIROLOGY REVIEW 2023
VIROLOGY REVIEW 2023
 
Virology 2022
Virology 2022Virology 2022
Virology 2022
 
Bacteriology Update 2021 (Part 1.)
Bacteriology Update 2021 (Part 1.)Bacteriology Update 2021 (Part 1.)
Bacteriology Update 2021 (Part 1.)
 
Virology 2021
Virology 2021Virology 2021
Virology 2021
 
Gram Stains 2021
Gram Stains 2021Gram Stains 2021
Gram Stains 2021
 
Mycology Update 2021
Mycology Update 2021Mycology Update 2021
Mycology Update 2021
 
Parasitology 2020
Parasitology 2020Parasitology 2020
Parasitology 2020
 
Antibiotic Sensitivity Testing 2020 Update
Antibiotic Sensitivity Testing 2020 Update Antibiotic Sensitivity Testing 2020 Update
Antibiotic Sensitivity Testing 2020 Update
 
Virology Review 2020
Virology Review 2020Virology Review 2020
Virology Review 2020
 
Mycology 2020
Mycology 2020Mycology 2020
Mycology 2020
 
Virology Review 2019
Virology Review 2019Virology Review 2019
Virology Review 2019
 
Bacteriology Update 2019
Bacteriology Update 2019Bacteriology Update 2019
Bacteriology Update 2019
 

Kürzlich hochgeladen

Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationnomboosow
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphThiyagu K
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactdawncurless
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingTechSoup
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfchloefrazer622
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...EduSkills OECD
 
9548086042 for call girls in Indira Nagar with room service
9548086042  for call girls in Indira Nagar  with room service9548086042  for call girls in Indira Nagar  with room service
9548086042 for call girls in Indira Nagar with room servicediscovermytutordmt
 
Disha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdfDisha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdfchloefrazer622
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introductionMaksud Ahmed
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13Steve Thomason
 
General AI for Medical Educators April 2024
General AI for Medical Educators April 2024General AI for Medical Educators April 2024
General AI for Medical Educators April 2024Janet Corral
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3JemimahLaneBuaron
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfsanyamsingh5019
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxheathfieldcps1
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxVishalSingh1417
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfAdmir Softic
 

Kürzlich hochgeladen (20)

Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communication
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot Graph
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdf
 
Advance Mobile Application Development class 07
Advance Mobile Application Development class 07Advance Mobile Application Development class 07
Advance Mobile Application Development class 07
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
9548086042 for call girls in Indira Nagar with room service
9548086042  for call girls in Indira Nagar  with room service9548086042  for call girls in Indira Nagar  with room service
9548086042 for call girls in Indira Nagar with room service
 
Disha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdfDisha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdf
 
Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13
 
General AI for Medical Educators April 2024
General AI for Medical Educators April 2024General AI for Medical Educators April 2024
General AI for Medical Educators April 2024
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdf
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 

Mycobacteriology Update 2020: Identification Methods

  • 2. Mycobacteria  Acid Fast Bacilli (AFB)  Thick outer cell wall contains complex mycolic acids (mycolates) and free lipids, contributes to the hardiness of the genus  Once stained, AFB resist de-colorization with acid alcohol (HCl), hence the term acid fast  Difference of AFB stain vs. modified or partial acid fast (PAF) stain  AFB stain uses HCl to decolorize Mycobacteria (+) Nocardia (-)  PAF stain uses H2SO4 to decolorize Mycobacteria (+) Nocardia (+)  AFB stain poorly with Gram stain / beaded Gram positive  Aerobic, no spores, rarely branch Kinyoun AFB stain Gram stain
  • 3. Identification of the Mycobacteria  For decades, identification algorithm started with determining the ability of a mycobacteria species to form cartenoid pigment in the light or dark; followed by biochemical reactions, growth rate, and optimum temperature for growth. Obsolete  With expanding taxonomy, biochemical reactions were unable to separate and identify most of the newly recognized species, so replaced with High Performance Liquid Chromatography (HPLC) methods. Now also obsolete  Current best methods for identification include:  Genetic probes (DNA/RNA hybridization)  MALDI-TOF Mass Spectrometry to analyze cellular proteins  Sequencing 16 sRNA for precise genetic sequence information
  • 4. Mycobacteria Taxonomy currently >170 species with 2 Taxonomic groups  Group 1 - TB complex organisms  Mycobacterium tuberculosis  M. bovis  Bacillus Calmette-Guerin (BCG) strain  Attenuated strain of M. bovis used for vaccination  M. africanum  Rare species of mycobacteria  Mycobacterium microti  Mycobacterium canetti  Mycobacterium caprae  Mycobacterium pinnipedii  Mycobacterium suricattae  Mycobacterium mungi  Group 2 - Mycobacteria other than TB complex (“MOTT”) also known as Non-Tuberculous Mycobacteria
  • 5. Non tuberculous mycobacteria that cause disease (1) Slowly growing non tuberculosis mycobacteria  M. avium-intracullare complex  M. genavense  M. haemophilum  M. kansasii (3) Mycobacterium leprae  M. malmoense  M. marinum  M. simiae  M. szulgai  M. ulcerans  M. xenopi  M. smegmatis (2) Rapid growing mycobacteria (growth in <= 7 days)  M. fortuitum group  M. abscessus  M. chelonae  M. mucogenicum
  • 6. Mycobacteria that rarely if ever cause disease! If so, only in the immunocompromised! Slowly growing nontuberculous mycobacteria  Mycobacterium gordonae  M. gastri  M. celatum  M. scrofulaceum  M. terrae complex
  • 7. Algorithm for identification of MOTT - historically speaking  Based on the “Runyon System”  System used to classify non-tuberculous mycobacteria  Based on carotenoid pigment production when exposed to incandescent light bulb & growth rate  Four Runyon groups  Photochromogen = Pigment produced only when exposed to light  Scotochromogen = Pigment produced in both light and dark  Non-photochromogen = No pigment produced in either light or dark  Rapid Grower = Growth rate (<= 7 days)
  • 8. The Light Test – Determine if mycobacteria can produce a yellow carotenoid pigment after being exposed to 8 hours of light/ after light exposure, incubate for 24 hours and observe for pigment. Group I Photochromogen Turns yellow only after light exposure Group III Non-photochromogen No pigment produced in dark or after light exposure Group II Scotochromogen Yellow pigment present in dark or with light exposure
  • 9. Runyon Classification System Classification  Group I - Photochromogen – turns yellow when exposed to light, no color in the dark. Growth in 2 -3 weeks  M. kansasii  M. simiae  M. szulgai photochromagen when incubated at 25˚C*  M. marinum  Group II - Scotochromogen – yellow pigment in dark or exposure to light. Growth 2 – 3 weeks  M. gordonae  M. scrofulaceum  M. xenopi (most strains)  M. szulgai scotochromogen when incubated at 37°C*
  • 10. Runyon Classification continued  Group III – Non-photochromogen – No pigment produced in the light or dark, growth in 2-3 weeks  M. avium-intracellulare complex  M. haemophilum  M. xenopi (some strains)  Group IV – Rapid growers, grow in <=7 days  M. fortuitum group  M. abscessus  M. chelonae  M. mucogenicum  M. smegmatis
  • 11. AFB Laboratory Safety  Level 3 biosafety precautions required in AFB laboratories that process, identify and perform susceptibility testing on mycobacteria species  Level 2 Hepa filter biosafety cabinet with return air vented to the outside  Biosafety certified at least yearly per regulation to insure proper operations  Room under negative air flow, anteroom for safety gear donning, and contiguous autoclave  Must wear a 95 respirator mask (yearly mask fit required) or PAPR (powered air purifying respiratory mask) when working with organisms even when inside the biosafety cabinet  Gloves and disposable surgical gowns for culture work  Plastic cups with tight lids used during high speed centrifugation Biosafety Cabinet PAPR Vented to outside
  • 12. Specimen collection  Sputum – 3 early morning collections, or 1 early morning, plus 2 collected at least 8 hours apart  Bronchial lavage fluid  Tissues or Lesions  CSF or sterile body fluids  Urine – 3 to 5 early morning collections  Stool – Primarily for M. avium-intracellulare complex  Gastric – usually only children unable to produce sputum, must neutralize gastric to pH 7.0 after collection in order for AFB to survive in stomach acid  Blood / Bone marrow in disseminated disease  Automated systems – AFB blood culture bottles manufactured specifically for AFB detection
  • 13. AFB Specimen Processing Start to Finish!  5 ml of specimen pipetted into conical Falcon tube  Decontaminate and liquify sputum specimen for 15 minutes with:  5 ml of 4% NaOH (increases the pH to 9) to kill contaminating bacteria  N-acetyl-L-Cysteine – liquifies mucus plugs  After 15 min - fill tube with phosphate buffer to neutralize to pH (7.0)  Centrifuge for 30 minutes – using safety cups with tight lids  3000 X g to pellet the AFB (speed is important – AFB are buoyant)  Pour off the supernatant  Prepare concentrated slide from pellet for AFB staining  Dilute the pellet with small amount of sterile saline for culture  Incubate culture media @ 37˚C, 5-10% CO2 for 6–8 weeks
  • 14. Why Decontaminate Specimens? Slow growing mycobacteria will be overgrown by “contaminating” bacteria in the sputum specimen unless they are killed in the decontamination step:  Competing bacteria/yeast grow approximately 24 x faster than AFB – these organisms are killed by the increased pH created by the addition of 4% NaOH  Must also release the AFB from mucus plugs in the sputum specimen - this is accomplished with the addition of the N-acetyl-L-Cysteine
  • 15. Specimen Decontamination/Digestion of potentially contaminated specimen types (respiratory)  Routine processing:  4% NaOH with N-acetyl-L-cysteine  Processing: special circumstances/ cystic fibrosis  Process sputum with oxalic acid to eliminate mucoid strains of Pseudomonas aeruginosa  4% NaOH will not kill these mucoid strains  Oxalic acid should not be used routinely for processing all specimens, will decrease yield of AFB in culture  Both 4% NaOH and Oxalic acid can kill AFB if left on specimen > 15 minutes.
  • 16. Specimen Centrifugation  Centrifugation at 3000 X g (high speed) with safety cups  Speed of centrifugation is important –  AFB are lipid laden and they will float if not rapidly centrifuged  Pellet to bottom of tube so they are not decanted with supernatant  Speed of centrifugation can effect the sensitivity of the AFB stain  Pour off supernatant into waste  Pellet used for stains/culture
  • 17. Manual Plating/Culture Media  Middlebrook – Synthetic media  Clear colored solid agar and liquid media  Synthetic = Known chemical ingredients added for optimal growth  Used for both culture and susceptibility testing  Autoclave to sterilize the media  Lowenstein-Jensen – Egg based  Solid agar, green due to addition of malachite green  Ingredients: Hens egg, glycerol, and potato flour  Used for culture only  Sterilize by inspissation – drying  Cultures incubated at 37˚C , 5-10% C0₂ for 6-8 weeks
  • 18. Automated Detection of AFB BD BACTEC MGIT 960 automated instrument for AFB  Middlebrook 12B liquid media used for the culture of AFB  BACTEC detection method  As AFB grow in the 12B media, the AFB respire CO₂ and the amount of O₂ is decreased over time. The lower level of O₂ causes fluorescence of the indicator and at the bottom of the tube and indicates organism growth in the tube.  Incubation at 37˚C for 6 weeks Fluorescence  NAP test /Identification of TB complex organisms using MGIT 960 instrument NAP = chemical (p-nitro-α-acetylamino-B-hydroxypropiophenone) TB complex does not grow in the tube containing NAP Non-tuberculous species grow in the tube containing the NAP chemical MGIT 960
  • 19. Acid Fast Stains for Mycobacteria  Carbol Fuchsin based stains  Carbol Fuchsin is red colored stain of the AFB  Potassium permanganate is the background blue counterstain  Two methods:  Ziehl-Neelsen (ZN) – heat used to drive stain into lipid laden AFB  Kinyoun – High % of phenol in stain drives stain into AFB  Read numerous microscopic fields for 5 minutes, using light microscopy using 100x oil objective
  • 20. Fluorochrome based stain  Auramine Rhodamine stain  Fluorescent stain  Rods stain fluorescent yellow with black background  Read on 25X or 40X for 2 min, viewing numerous fields using a fluorescence microscope  Based on nonspecific fluoro-chrome that binds to the mycolic acids in the mycobacteria  Considered more sensitive than ZN or Kinyoun stains for concentrated patient specimen slide examination
  • 21. Acid Fast Mycobacteria morphology Mycobacterium avium complex Organisms are routinely shorter than TB (Kinyoun stain) without cording. The organisms tend to clump. M. tuberculosis - Organisms are long rods and can appear as if they are sticking together [due ti cord factor] In broth cultures - ropes of AFB can form due to cord factor
  • 22. Direct Detection of TB from Respiratory Specimens using Molecular Amplification  FDA cleared DNA PCR that detects TB complex organisms in < 2 hrs for both AFB smear positive and negative sputum specimens:  Cepheid Xpert-TB RIF Assay (rtPCR) tested on the Genexpert instrument  Detects TB complex organism gene sequence and rifampin resistance gene (rpoB)  Sensitivity of assays  99% for AFB concentrated smear (+) specimens  75% for AFB concentrated smear (-) specimens  Test of diagnosis, not cure  Residual rRNA and DNA can be present for up to 6 months after initial diagnosis and start of therapy  Must confirm all tests with AFB culture and sensitivity (gold standard)  Currently, no FDA cleared assay for non-tuberculous mycobacteria spp.
  • 23. PPD (Purified Protein Derivative) Mantoux test/TB skin test  Detects latent or current TB exposure  False positive reactions can occur in patients immunized with BCG  @ 25% false negative reactions  Usually due to low T cell numbers or T cell reactivity, such as occurs with high dose steroids.  Technical problems with PPD administration and test interpretation can also lead to false negative or false positive reactions  Measures delayed hypersensitivity (T cell response) to TB complex antigens (not specific for TB)  Measure (mm) area of induration at injection site  >=15mm positive (check for history of BCG)  >=10mm positive in immune suppressed or just exposed to TB and part of an outbreak investigation
  • 24. Cell Mitogen assays – Interferon Gamma Release Assays (IGRA)s  QuantiFERON-TB-Gold Plus (QFTP)  CD4 and CD8 T cells in patient whole blood samples are stimulated with TB specific antigens.  If patient has active or latent exposure to TB, the stimulated T cells will produce gamma interferon  Automated EIA assay measures amount of gamma interferon produced  Quantitative endpoint indicates a positive or negative reaction  Indeterminate reactions can occur, if T cells are absent or inactive due to medications  No false positive reactions from immunization with BCG  Sensitivity >=80%, does NOT replace culture for disease diagnosis  Sensitivity similar to PPD/ but has improved specificity
  • 25. Mycobacterium tuberculosis  Optimal Temp 37˚ C, Growth in 12 –25 days  Buff colored, dry cauliflower-like colony  Manual tests for identification – old school  Niacin accumulation test positive  Niacin produced from growth of TB on egg containing medium (LJ)  Nitrate reduction test positive  Current identification methods:  Molecular DNA/RNA hybridization probe for MTB complex  MALDI-TOF mass spectrometry for M. tuberculosis  16 sRNA sequencing for M. tuberculosis
  • 26. Mycobacterium tuberculosis Cord factor – Due to high lipid content in cell wall, rods stick together and develop long ropes when grown in broth media – unique to M. tuberculosis Long AFB / stick together
  • 27. Susceptibility testing of TB  Two methods for testing  (1) Agar dilution (indirect proportion method)  Antibiotics embedded in solid agar and TB inoculated onto media quadrants  (2) Liquid 7H12 medium containing anti-TB antibiotic solutions  Tested on automated Bactec MGIT 960 system  Primary TB drug panel / 5 drugs  Isoniazid Ethambutol  Pyrazinamide Streptomycin  Rifampin  If resistant to primary drugs, second line drugs tested  Fluoroquinolones, Kanamycin, Amikacin, and Capreomycin  If patient remains culture positive after four months on treatment/ retest the TB susceptibility / possible drug resistant strain
  • 28. Tuberculosis  Classic disease is slowly progressive pulmonary infection cough, weight loss, and low grade fever, presentation can vary depending on degree of immune suppression:  Ghon’s complex: Lesion with calcified foci of infection and an associated lymph node  Miliary TB: Wide spread dissemination of infection via the bloodstream, occurs most often in AIDS, elderly, children, immunosuppression and with some medications (Remicade- infliximab)  Secondary tuberculosis: mostly in adults as reactivation of previous infection  Granulomatous inflammation much more florid and widespread than in primary disease.  Upper lung lobes are most affected, and cavitation can occur.  TB is spread by respiratory droplets  All patients with high level of suspicion require respiratory isolation precautions TB infection Lung nodules
  • 29. Pathology of Mycobacterium tuberculosis Hallmark of Mycobacterium tuberculosis infected tissue is necrotizing granulomatous inflammation, • composed of epithelioid histiocytes surrounding a central necrotic zone, and • accompanied by a variable number of multinucleated giant cells and lymphocytes. • Non-necrotizing granulomas can also be present. Nodule with cavitation Necrotizing granuloma
  • 30. TB in HIV/AIDS patients  Worldwide -TB is the most common opportunistic infection affecting HIV/AIDS patients  TB more likely to be multi-drug resistant (at least INH and Rifampin)  With progressive decline of cell mediated immunity (low CD4 count) – greater risk of extra pulmonary (miliary) dissemination  Granulomas with/without caseation can occur Miliary TB
  • 31. M. tuberculosis outside the lung  Scrofula –Unilateral lymphadenitis (cervical lymph node) most often seen in immunocompromised adult or children/ caseous necrosis often present  Fine needle aspiration for diagnostic specimen  M. tuberculosis most common in adults  M. avium complex and other MOTT (2-10%) in children  Pott’s disease - TB infection of the spine  Secondary to an extra-spinal source of infection (1* pulmonary)  Manifests as a combination of osteomyelitis and arthritis that usually involves more than 1 vertebra.
  • 32. Mycobacterium bovis  Produces disease in warm blooded animals, cattle  Spread to humans by inhalation of droplets or raw milk products  Disease in humans similar to that caused by TB  Differentiation of M. bovis from M. tuberculosis M.bovis M. tb Nitrate Negative Positive Growth in T2H* No growth Growth Pyrazinamidase enzyme Negative Positive Pyrazinamide susceptibility Resistant Susceptible *(Thiophene-2-carboxylic hydrazide)  M. bovis BCG (Bacillus Calmette-Guerin)  BCG is an attenuated strain of M. bovis  Used for TB vaccination in countries with high prevalence of TB  Instillation of BCG into bladder can be used to treat bladder cancer / some patients become infected with the M. bovis BCG
  • 33. Mycobacterium ulcerans  Buruli ulcer in Africa and known as Bairnsdale ulcer in Australia  Localized painless skin nodule evolves rapidly to ulceration and can become disabling, due to production of mycolactones (cell cytotoxin)  Endemic in tropical areas with limited medical care, mild skin trauma with exposure to contaminated stagnant waters leads to progressive and destructive ulcers, peak age group 5-15 yrs  Optimum growth temp @ 30˚ C  Does not grow well or at all at 37*C  **Skin lesions suspect for AFB should be cultured at both 30˚ and 37˚C  Difficult / slow growing requiring 3- 4 weeks/ molecular techniques preferred
  • 34. Mycobacterium kansasii  Culture 37* C, 10-20 days  Photochromogen  Niacin accumulation test negative  Nitrate reduction positive  Tween 80 positive / tests for presence of the lipase enzyme  68*C catalase positive  AFB are larger than TB - rectangular and very beaded with Shepherd’s crook shape  Clinical disease mimics pulmonary TB but less likely to disseminate  Disease acquired from contaminated tap water  Predisposition for diseased lung (COPD)  More likely seen in immune suppressed, pneumoconiosis, alcohol abuse, and HIV  Produces granulomatous inflammation in lung
  • 35. Mycobacterium marinum  Photochromogen  Optimum temp for growth is 30˚ C  Grows poorly or not at all at 37°C  Grows in 5-14 days  Normal habitat is contaminated fresh and salt water  Infection associated with skin trauma occurring in water, such as  Swimming pools (swimming pool granuloma)  Cleaning fish tanks with bare hand and arm  Ocean (surfing)  Punctures from fish fins
  • 36. Mycobacterium marinum  Disease: Tender, red or blue/red subcutaneous nodules develop at the site of trauma after 2-3 weeks  Biopsy skin nodules for culture and histopathology  Lesions classically spread up arm along lymphatics,  Infection appears similar to diseases Sporotrichosis, Nocardiosis, and infection with rapid growing Mycobacteria species
  • 37. Mycobacterium szulgai  Scotochromogen at 37˚C / Photochromogen at 25˚C  Only AFB species that has a different light test result based on temperature of incubation  Grows at 37 ˚C in 12 - 25 days  Rare cause of pulmonary disease in adults associated with alcohol abuse , smoking and COPD or those with AIDS and immune suppressed  Symptoms similar to TB 25˚ C - Photochromogen 37˚ C - Scotochromogen
  • 38. Mycobacterium xenopi  Scotochromogen  Thermophilic AFB with growth at 42˚C  Capable of growing in hot water systems and is the usual source of infection  Growth in 14 - 28 days  Egg nest type colony produced on solid media  Rare cause of pulmonary disease  Clinical disease is like TB  Occurs in patients with preexisting lung disease (chronic obstructive pulmonary disease or bronchiectasis) and HIV/AIDS
  • 39. M. avium complex  M avium & M intracellulare most common species in this complex,  The complex includes eight species of environmental and animal AFB  Non-photochromogen  All species biochemically and genetically very similar  Growth at 37 ˚C / 7 – 21 days  Smooth / creamy colony / buff colored  Short rods, not beaded, irregular clumps of AFB  Inert in biochemical reactions  Identify using  Molecular DNA/RNA hybridization probe (M. avium complex)  MALDI-TOF mass spectrometry (species within complex)  16s rRNA sequencing (species within complex)
  • 40. M. avium complex clinical correlation  Disease in the somewhat normal host  Adults mostly have chronic pulmonary disease, fibro-cavitary or nodular bronchiectatic disease presentation  Elderly adults with prior lung damage (COPD) produces chronic cough  Children – chronic granulomatous inflammation with lymph node involvement / scrofula  M. chimaera (a species within the M. avium complex)  Environmental / nosocomial pathogen  Recently in the news as a contaminate in heater–cooler units used in cardiac surgery/ aerosolized water from instrument positive with M. chimaera  The airborne transmission of M. chimaera over an open surgical field caused post surgical infections
  • 41. M. avium complex (MAC)  HIV/AIDS – common opportunistic infection in AIDS  Nonspecific low grade fever, weakness, weight loss, picture of fever of unknown origin rather than a pulmonary infection  Diagnosis: Isolation of MAC from an AFB blood cuor bone marrow culture  Abdominal pain and/or diarrhea with malabsorption  Positive AFB smears from stool specimens  In tissue:  Pathology: non-necrotizing more so than granulomatous  High organism load in infected tissue  AFB are small (short) rods and not beaded  Does not have cord factor
  • 42. M avium-complex in lymph node tissue (AFB Kinyoun stain) – packed with AFB Granulomatous inflammation lung tissue (H&E stain) Bowel -Lamina propria expanded from predominately Lymphohistocytic infiltration
  • 43.  Grows in <=7 days, more rapid than other mycobacteria species  Low virulence organisms, with most species found as environmental contaminates  20 species – 3 species most common  M. fortuitum skin and surgical wound infections, catheter sites  M. chelonae skin infections in immune suppressed, catheter sites  M. abscessus chronic lung infection and skin infection in immune suppressed  Biochemical reactions:  All species Arylsulfatase positive  M. fortuitum: Nitrate reduction positive Iron uptake positive  M. chelonae and M. abscessus: Nitrate negative Rapid Grower Mycobacteria species
  • 44.  MALDI-TOF and 16 sRNA sequencing for identification  Antibiotic therapy assisted by directed susceptibility tests  Varying susceptibility patterns/ clarithromycin primary therapy  Molecular genetic testing can assist with clarithromycin testing
  • 45. Miscellaneous  M. gordonae –  Scotochromogen  Rarely if ever causes infection  Commonly found in tap water  Find it’s way into AFB cultures as a laboratory contaminant  Use sterile/distilled water in AFB culture collection and processing to prevent culture contamination
  • 46. Miscellaneous pathogenic species  Mycobacterium haemophilum  Fastidious AFB, requires addition of hemoglobin or hemin to culture media for growth  Will not grow on LJ media or in automated systems (Middlebrook 12B media) without the addition of hemin supplements  Grows best at 30*C  Disease:  Painful subcutaneous nodules and ulcers, primarily in AIDS patients or immunosuppressed  Lymphadenitis in children
  • 47. Mycobacterium leprae  Leprosy – Hansen’s Disease  Affects the skin, peripheral nervous system and mucous membranes  Clinical signs and symptoms aid in diagnosis: Peripheral neuropathy with nerve thickening, numbness in earlobes or nose, loss of eye brows  Infection by person-person spread via inhalation of infectious droplets  Curable with early diagnosis and appropriate therapy (dapsone with rifampin or clofazimine  Two types of leprosy / most often found in India, Brazil and Indonesia  Lepromatous – Severe disfiguring lesions, large numbers of AFB in lesions  Tuberculoid - Less severe and fewer lesions, lower numbers of AFB in lesions  Non-culturable on laboratory media  PCR performed from tissue for definitive diagnosis  Armadillo is a natural reservoir of M. leprae
  • 48. Tuberculoid leprosy/ Paucibacillary Lepromatous leprosy /Multibacillary Skin biopsy - AFB seen in nerve fiber AFB in “cigar packet” arrangement